Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hovione, IDC Partner on Nasal Powder Delivery Device | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Hovione, IDC Partner on Nasal Powder Delivery Device

New active nasal powder delivery devices are designed to enable broad and targeted nasal deposition flexibility

By: Anthony Vecchione

Hovione, a contract development and manufacturing organization (CDMO) specializing in spray drying and particle engineering, is expanding its nasal drug delivery capabilities with the addition of a family of nasal powder delivery devices developed in partnership with Industrial Design Consultancy (IDC). 

Hovione and IDC have been working together to accelerate the development and commercialization of two new active nasal powder delivery devices, one single-use and one multidose. The devices are designed to enable broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. By using standard capsules and filling equipment, they also have the potential to simplify drug product development and manufacturing.

Hovione will offer the new devices on an exclusive basis as part of its integrated offering for nasal drug development and manufacturing.

“Intranasal drug delivery is gaining momentum across a number of applications, including mucosal vaccination and CNS treatments bypassing the blood-brain barrier,” said Jean-Luc Herbeaux, Hovione’s CEO. “Our partnership with IDC, a company with vast experience in industrial design, mechanical and electronic engineering of medical devices, enables Hovione to offer a complete solution for nasal powder delivery – covering APIs, formulation, filling, analytics and device design and manufacturing,” said Herbeaux.

Stephen Knowles, IDC´s managing director said, “By combining Hovione’s capabilities in pharmaceutical development, formulation and manufacturing with IDC’s device development expertise, this partnership offers customers a nasal powder delivery solution which can be rapidly adapted to new pharma compounds and therapies. Our joint development team has done incredible work to create unique, high performance nasal powder delivery devices.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics